Pharma.Aero releases white paper on sustainability project
Paper introduces an index known as the LSRI to assess sustainability readiness in the airport-to-airport supply chain.
Pharma.Aero, a leading organisation in the life science logistics industry, released a white paper detailing the findings of the Green Air Pharma Logistics Project (GAPL).
The paper explores sustainability challenges within healthcare supply chain logistics and introduces a comprehensive index known as the Lane Sustainability Readiness Index (LSRI) to measure the sustainability readiness of stakeholders throughout the airport-to-airport supply chain.
The collaborative effort will identify key quantitative and qualitative indicators defining a green air lane, involving various stakeholders along the supply chain including life science manufacturers, airports, airlines, cargo handlers, and solution providers, says an official release.
LSRI will be a tool to support life science companies and freight forwarders to integrate sustainability considerations into freight procurement and lane assessment processes as part of their efforts in achieving Scope 3 targets. Additionally, it is aimed at supporting freight forwarders and airlines in developing low-emissions products and value propositions aligned with their customers’ sustainability goals, the release added.
"The decarbonisation of air transportation is a multifaceted journey," says Jaisey Yip, project lead and Vice President, of the Cargo Business Division, Changi Airport Group and a strategic member of Pharma.Aero. "Beyond the life science industry, the LSRI is cross-sectoral and aims to provide value to all stakeholders within the air cargo value chain.
"The GAPL project paves the way for Pharma.Aero and the industry to explore new avenues towards more sustainable air logistics. We anticipate the LSRI's application beyond the airport-to-airport boundary.”
Sara Van Lerberghe, Projects Coordinator, Pharma.Aero emphasises the project’s collaborative methods, leveraging the collective expertise of Pharma. Aero’s global membership: "We commend all our members and partners for their invaluable contributions to this project. Their dedication was pivotal in acquiring firsthand insights into industry sustainability objectives and identifying essential indicators for evaluating lane sustainability readiness.”
